Apotheek Duchi: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
Apotheek Duchi
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€59,603
2024 · €57,700+€1,903
Equity
€325,738
2024 · €325,135+€603
Cash
€33,582
2024 · €58,640-€25,058
Balance sheet total
€745,540
2024 · €787,490-€41,949
Largest movements
Assets
- Cash -€25,058
down €25,058 (-42.7%), from €58,640 to €33,582
mainly Contributions, distributions and other (-€59,000) and Investment in fixed assets (net) (-€17,610)
- Receivables within one year -€9,727
down €9,727 (-5.4%), from €180,998 to €171,272
of which Trade receivables: -€6,789
Equity and liabilities
- Trade debts -€13,621
down €13,621 (-23.0%), from €59,155 to €45,533
- Debts after one year -€12,917
down €12,917 (-4.6%), from €283,280 to €270,363
Income statement
- Staff costs -€2,511
down €2,511 (-2.8%), from €88,625 to €86,114
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€57,700
Gross operating margin
+€1,619
Staff costs
+€2,511
Depreciation
-€1,086
Other operating charges
-€255
Financial income
-€793
Financial charges
-€272
Taxes
+€179
Result 2025
€59,603
raises the resultlowers the result
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€65,215
Investment
-€17,610
Financing
-€72,663
Cash 2024
€58,640
From operations (derived)
+€65,215
Net result for the year
+€59,603
Depreciation
+€21,013
Stocks and contracts
+€2,751
Receivables within one year
+€9,727
Deferred charges and accrued income
+€1,011
Trade debts
-€13,621
Tax, wage and social debts
-€7,664
Other debts
-€7,610
Accrued charges and deferred income
+€5
Investment (derived)
-€17,610
Investment in fixed assets (net)
-€17,610
Financing
-€72,663
Debts after one year
-€12,917
Current portion of long-term debt
-€746
Contributions, distributions and other
-€59,000
Cash 2025
€33,582
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €787,490 | €745,540 | -€41,949 | -5.3% |
| Fixed assets | 21/28 | €329,956 | €326,553 | -€3,403 | -1.0% |
| Tangible fixed assets | 22/27 | €329,931 | €326,528 | -€3,403 | -1.0% |
| Land and buildings | 22 | €319,095 | €313,147 | -€5,949 | -1.9% |
| Plant, machinery and equipment | 23 | €8,098 | €6,207 | -€1,891 | -23.4% |
| Furniture and vehicles | 24 | €2,738 | €7,174 | +€4,437 | +162% |
| Financial fixed assets | 28 | €25 | €25 | = | 0.0% |
| Current assets | 29/58 | €457,534 | €418,987 | -€38,546 | -8.4% |
| Stocks and contracts in progress | 3 | €215,533 | €212,783 | -€2,751 | -1.3% |
| Stocks | 30/36 | €215,533 | €212,783 | -€2,751 | -1.3% |
| Amounts receivable within one year | 40/41 | €180,998 | €171,272 | -€9,727 | -5.4% |
| Trade receivables | 40 | €94,895 | €88,107 | -€6,789 | -7.2% |
| Other amounts receivable | 41 | €86,103 | €83,165 | -€2,938 | -3.4% |
| Cash at bank and in hand | 54/58 | €58,640 | €33,582 | -€25,058 | -42.7% |
| Deferred charges and accrued income | 490/1 | €2,362 | €1,351 | -€1,011 | -42.8% |
| Total equity and liabilities | 10/49 | €787,490 | €745,540 | -€41,949 | -5.3% |
| Equity | 10/15 | €325,135 | €325,738 | +€603 | +0.2% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €306,535 | €307,138 | +€603 | +0.2% |
| Tax-exempt reserves | 132 | €16 | €16 | = | 0.0% |
| Distributable reserves | 133 | €306,519 | €307,122 | +€603 | +0.2% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €462,355 | €419,803 | -€42,552 | -9.2% |
| Amounts payable after more than one year | 17 | €283,280 | €270,363 | -€12,917 | -4.6% |
| Financial debts | 170/4 | €283,280 | €270,363 | -€12,917 | -4.6% |
| Amounts payable within one year | 42/48 | €179,003 | €149,362 | -€29,641 | -16.6% |
| Current portion of amounts payable after more than one year | 42 | €27,351 | €26,605 | -€746 | -2.7% |
| Trade debts | 44 | €59,155 | €45,533 | -€13,621 | -23.0% |
| Suppliers | 440/4 | €59,155 | €45,533 | -€13,621 | -23.0% |
| Taxes, remuneration and social security | 45 | €13,541 | €5,877 | -€7,664 | -56.6% |
| Taxes | 450/3 | €348 | €522 | +€175 | +50.2% |
| Remuneration and social security | 454/9 | €13,193 | €5,355 | -€7,838 | -59.4% |
| Other amounts payable | 47/48 | €78,957 | €71,347 | -€7,610 | -9.6% |
| Accrued charges and deferred income | 492/3 | €72 | €77 | +€5 | +7.5% |
| Remuneration, social security and pensions | 62 | €88,625 | €86,114 | -€2,511 | -2.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €19,927 | €21,013 | +€1,086 | +5.4% |
| Other operating charges | 640/8 | €3,527 | €3,782 | +€255 | +7.2% |
| Gross operating margin | 9900 | €174,017 | €175,636 | +€1,619 | +0.9% |
| Operating profit (loss) | 9901 | €61,938 | €64,727 | +€2,790 | +4.5% |
| Financial income | 75/76B | €4,743 | €3,950 | -€793 | -16.7% |
| Recurring financial income | 75 | €4,743 | €3,950 | -€793 | -16.7% |
| Financial charges | 65/66B | €8,320 | €8,593 | +€272 | +3.3% |
| Recurring financial charges | 65 | €8,320 | €8,593 | +€272 | +3.3% |
| Profit (loss) for the period before taxes | 9903 | €58,361 | €60,085 | +€1,724 | +3.0% |
| Income taxes | 67/77 | €661 | €482 | -€179 | -27.1% |
| Profit (loss) for the period | 9904 | €57,700 | €59,603 | +€1,903 | +3.3% |
| Profit (loss) for the period to be appropriated | 9905 | €57,700 | €59,603 | +€1,903 | +3.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 October 2026 via checked.be.